Myocardial delayed enhancement using a single dose (0.1 mmol/kg) of gadobenate dimeglumine: Contrast resolution versus intraventricular blood and viable myocardium;Delayed enhancement miocardico con singola dose (0.1 mmol/kg) di gadobenato dimeglumina: risoluzione di contrasto rispetto al sangue ventricolare ed al miocardio sano

Radiologia Medica

Volumn 115, Issue 5, 2010, Pages 693-701

  Papini, G D E ^a   Tritella, S ^a   Secchi, F ^a   Aliprandi, A ^a   Di Leo, G ^a   Sardanelli, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cardiac magnetic resonance (CMR); Delayed enhancement (DE); Gadobenate dimeglumine (Gd BOPTA); Gadoterate meglumine (Gd DOTA); Myocardium

Indexed keywords

CONTRAST MEDIUM; DRUG DERIVATIVE; GADOBENIC ACID; GADOLINIUM 1,4,7,10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETATE; GADOTERIC ACID; HETEROCYCLIC COMPOUND; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ARTICLE; COMPUTER ASSISTED DIAGNOSIS; FEMALE; HEART INFARCTION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RETROSPECTIVE STUDY;

CONTRAST MEDIA; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 77955466171     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-010-0495-2     Document Type: Article

References (21)

1. R.J. Kim D.S. Fieno T.B. Parrish 1999 Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1922 2002
2. J.B. Selvanayagam A. Kardos J.M. Francis 2004 Value of delayed enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization Circulation 110 1535 1541 10.1161/01.CIR.0000142045.22628.74 15353496 (Pubitemid 39297973)
3. R.J. Kim E. Wu A. Rafael 2000 The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 1445 1453 10.1056/NEJM200011163432003 1:STN:280:DC%2BD3M%2FisFWnsw%3D%3D 11078769
4. J. Vogel-Claussen C.E. Rochitte K.C. Wu 2006 Delayed enhancement MR imaging: utility in myocardial assessment Radiographics 26 795 810 10.1148/rg.263055047 16702455 (Pubitemid 43824977)
5. R.M. Judd R.J. Kim 2002 Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging Circulation 106 e6 10.1161/01.CIR.0000019903.37922.9C 12105174
6. T. Schlosser P. Hunold C.U. Herborn 2005 Myocardial infarct: depiction with contrast-enhanced MR imaging-comparison of gadopentetate and gadobenate Radiology 236 1041 1046 10.1148/radiol.2363040220 16055693 (Pubitemid 41170871)
7. F. Sardanelli M. Quarenghi 2006 Delayed enhancement of subendocardial infarcted myocardium with gadobenate dimeglumine: a paradoxical effect-Is a double dose too much Radiology 3 914 916 10.1148/radiol.2403051674 (Pubitemid 44267356)
8. N.C. Balci N. Inan Y. Anik 2006 Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging Acad Radiol 13 833 839 10.1016/j.acra.2006.04.002 16777557 (Pubitemid 43866530)
9. K. Thygesen J.S. Alpert H.D. White Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction 2007 Universal definition of myocardial infarction Circulation 116 2634 2653 10.1161/CIRCULATIONAHA.107. 187397 17951284 (Pubitemid 350182388)
10. R.R. Edelman 2004 Contrast-enhanced MR imaging of the heart: overview of the literature Radiology 232 653 668 10.1148/radiol.2323031558 15284429 (Pubitemid 39100246)
11. K.U. Bauner M.F. Reiser A.M. Huber 2009 Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine Invest Radiol 44 95 104 10.1097/RLI.0b013e3181911eab 1:CAS:528:DC%2BD1MXit1ertr0%3D 19077911
12. F.M. Cavagna F. Maggioni P.M. Castelli 1997 Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging Invest Radiol 32 780 796 10.1097/00004424-199712000-00009 1:CAS:528:DyaK2sXnvFGhur4%3D 9406019 (Pubitemid 28053510)
13. F.M. Cavagna P. Marzola M. Daprà 1994 Binding of gadobenate dimeglumine to proteins extravasated into interstitial space enhances conspicuity of reperfused infarcts Invest Radiol 29 Suppl2 S50 S53 10.1097/00004424-199406001-00018 7928270
14. J. Pintaske P. Martirosian H. Graf 2006 Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla Invest Radiol 41 213 221 10.1097/01.rli.0000197668.44926.f7 16481903 (Pubitemid 44406181)
15. F.L. Giesel H. von Tengg-Kobligk I.D. Wilkinson 2006 Influence of human serum albumin on longitudinal and transverse relaxation rates (R1 and R2) of magnetic resonance contrast agents Invest Radiol 41 222 228 10.1097/01.rli. 0000192421.81037.d5 1:CAS:528:DC%2BD28XhsVKqtrw%3D 16481904 (Pubitemid 44406182)
16. A. Wagner H. Mahrholdt T.A. Holly 2003 Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study Lancet 361 374 379 10.1016/S0140-6736(03)12389-6 12573373 (Pubitemid 36164969)
17. V.S. Lee D. Resnick S.S. Tiu 2004 MR imaging evaluation of myocardial viability in the setting of equivocal SPECT results with (99m)Tc sestamibi Radiology 230 191 197 10.1148/radiol.2301030070 14617765 (Pubitemid 37549801)
18. D.R. Broome M.S. Girguis P.W. Baron 2007 Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned AJR Am J Roentgenol 188 586 592 10.2214/AJR.06.1094 17242272 (Pubitemid 46167763)
19. E.A. Sadowski L.K. Bennett M.R. Chan 2007 Nephrogenic systemic fibrosis: risk factors and incidence estimation Radiology 243 148 157 10.1148/radiol. 2431062144 17267695 (Pubitemid 46579705)
20. M.R. Prince H. Zhang M. Morris 2008 Incidence of nephrogenic systemic fibrosis at two large medical centers Radiology 248 807 816 10.1148/radiol. 2483071863 18710976
21. G. Ligabue F. Fiocchi S. Ferraresi 2008 3-Tesla MRI for the evaluation of myocardial viability: a comparative study with 1.5-Tesla MRI Radiol Med 113 347 362 10.1007/s11547-008-0256-7 1:STN:280:DC%2BD1cvpvVOrtg%3D%3D 18493772 (Pubitemid 351725518)